Vx-950 and Loraz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vx-950 and Loraz. Common interactions include urinary tract infection among females and fatigue among males.

The phase IV clinical study analyzes what interactions people who take Vx-950 and Loraz have. It is created by eHealthMe based on reports of 28 people who take Vx-950 and Loraz from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Mar, 24, 2023

28 people who take Vx-950 and Loraz together, and have interactions are studied.


What is Vx-950?

Vx-950 has active ingredients of telaprevir. eHealthMe is studying from 9,465 Vx-950 users for its effectiveness, alternative drugs and more.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 145,138 Loraz users for its effectiveness, alternative drugs and more.

Number of Vx-950 and Loraz reports submitted per year:

Vx-950 and Loraz drug interactions.

Common Vx-950 and Loraz drug interactions by gender *:

female:

  1. Urinary tract infection
  2. Nausea
  3. Fatigue
  4. Rash
  5. Pruritus
  6. Vomiting
  7. Abdominal pain
  8. Dysgeusia
  9. Influenza like illness
  10. Platelet count decreased

male:

  1. Fatigue
  2. Diarrhoea
  3. Injection site erythema
  4. Nausea
  5. Platelet count decreased
  6. Psychotic disorder
  7. Stomatitis
  8. Rash
  9. Asthenia
  10. Biliary anastomosis complication

Common Vx-950 and Loraz drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Throat tightness
  2. Urinary tract infection
  3. Vomiting
  4. Fatigue
  5. Nausea
  6. Dizziness
  7. Dysgeusia
  8. Biliary anastomosis complication
  9. Blood alkaline phosphatase increased
  10. Blood creatine phosphokinase increased

50-59:

  1. Nausea
  2. Fatigue
  3. Abdominal pain
  4. Rash
  5. Vomiting
  6. Platelet count decreased
  7. Constipation
  8. Diarrhoea
  9. Injection site erythema
  10. Liver disorder

60+:

  1. Rash
  2. Nausea
  3. Dry throat
  4. Dyspnoea
  5. Eating disorder
  6. Fatigue
  7. Headache
  8. Leukopenia
  9. Lung infection
  10. Pancreatitis acute

Common conditions people have *:

  1. Hepatitis C: 24 people, 85.71%
  2. Insomnia (sleeplessness): 4 people, 14.29%
  3. Rashes (redness): 2 people, 7.14%
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 7.14%
  5. Itching: 2 people, 7.14%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 7.14%
  7. High Blood Pressure: 2 people, 7.14%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 7.14%
  9. Fever: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Vx-950 and Loraz?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Vx-950 and Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vx-950 side effects:

Browse all side effects of Vx-950:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Loraz side effects:

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vx-950 interactions:

Browse all interactions between Vx-950 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Loraz interactions:

Browse all interactions between Loraz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on telaprevir and lorazepam (the active ingredients of Vx-950 and Loraz, respectively), and Vx-950 and Loraz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Vx-950 and Loraz.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: